======= METTL1 ======= == Gene Information == * **Official Symbol**: METTL1 * **Official Name**: methyltransferase like 1 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=4234|4234]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9UBP6|Q9UBP6]] * **Interactions**: [[https://thebiogrid.org/search.php?search=METTL1&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20METTL1|Open PubMed]] * **OMIM**: [[https://omim.org/entry/604466|Open OMIM]] == Function Summary == * **Entrez Summary**: This gene is similar in sequence to the S. cerevisiae YDL201w gene. The gene product contains a conserved S-adenosylmethionine-binding motif and is inactivated by phosphorylation. Alternative splice variants encoding different protein isoforms have been described for this gene. A pseudogene has been identified on chromosome X. [provided by RefSeq, Jul 2008]. * **UniProt Summary**: Catalyzes the formation of N(7)-methylguanine at position 46 (m7G46) in tRNA. {ECO:0000255|HAMAP-Rule:MF_03055, ECO:0000269|PubMed:12403464}. |Methyltransf 4| |tRNA (guanine-N7)-methylation| |tRNA (guanine-N7-)-methyltransferase activity| |RNA (guanine-N7)-methylation| |tRNA methylation| |tRNA binding| |RNA methylation| |tRNA modification| |tRNA processing| |RNA modification| |tRNA metabolic process| |macromolecule methylation| |methylation| |ncRNA processing| |ncRNA metabolic process| |nucleolus| |RNA processing| |RNA metabolic process| |gene expression| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp25|Oligomycin-A 2μM R00 exp25]]|1.7| |[[:results:exp82|Torin1 0.08μM R02 exp82]]|1.72| |[[:results:exp71|KU-0063794 3.8μM R02 exp71]]|1.76| |[[:results:exp59|UMK57 1μM R01 exp59]]|1.81| |[[:results:exp356|Docosahexaenoic-acid 50μM R07 exp356]]|1.82| |[[:results:exp147|Resveratrol 16μM R03 exp147]]|1.82| |[[:results:exp143|Phenformin 20μM R03 exp143]]|1.83| |[[:results:exp70|INK128 0.2μM R02 exp70]]|1.84| |[[:results:exp529|Thimerosal 0.85μM R08 exp529]]|1.84| |[[:results:exp363|GSK-J4 1-1.25μM to day4 R07 exp363]]|1.86| |[[:results:exp525|Sulforaphane 9μM R08 exp525]]|1.88| |[[:results:exp350|Deferoxamine 11μM R07 exp350]]|1.9| |[[:results:exp407|Thapsigargin 0.005μM R07 exp407]]|1.91| |[[:results:exp343|Centrinone 0.5μM R07 exp343]]|1.92| |[[:results:exp226|Cerivastatin 0.15μM R05 exp226]]|1.96| |[[:results:exp242|Radicicol 0.16μM R05 exp242]]|1.96| |[[:results:exp346|CoCl2 18μM R07 exp346]]|1.97| |[[:results:exp329|Hydroxyurea 100μM R07 exp329]]|2| |[[:results:exp526|Sulforaphane 9μM R08 exp526 no dilution day6]]|2.02| |[[:results:exp445|∆-9-Tetrahydrocannabinol 30μM R08 exp445]]|2.12| |[[:results:exp466|Cannabidiol 20μM R08 exp466]]|2.14| |[[:results:exp400|Senexin-A 25μM R07 exp400]]|2.14| |[[:results:exp504|MK2206 4μM R08 exp504]]|2.16| |[[:results:exp440|Aphidicolin 0.4μM R08 exp440]]|2.2| |[[:results:exp269|Bisphenol A 100μM R06 exp269]]|2.2| |[[:results:exp47|Lapatinib 5μM R01 exp47]]|2.21| |[[:results:exp450|Artemisinin 50μM R08 exp450]]|2.33| |[[:results:exp334|All-trans-Retinoic-Acid 40μM R07 exp334]]|2.4| |[[:results:exp468|CB-5083 0.4μM R08 exp468]]|2.44| |[[:results:exp320|ABT-702 5μM plus CoCl2 18μM R07 exp320]]|2.46| |[[:results:exp275|Citral 75μM R06 exp275]]|2.49| |[[:results:exp399|Salubrinal 20μM R07 exp399]]|2.5| |[[:results:exp321|ABT-702 5μM plus Deferoxamine 11μM R07 exp321]]|2.63| |[[:results:exp227|Cryptotanshinone 12μM R05 exp227]]|3.17| ^Gene^Correlation^ |[[:human genes:t:trmt61a|TRMT61A]]|0.596| |[[:human genes:p:pmvk|PMVK]]|0.57| |[[:human genes:p:prim1|PRIM1]]|0.53| |[[:human genes:p:ppcdc|PPCDC]]|0.529| |[[:human genes:d:dnlz|DNLZ]]|0.506| |[[:human genes:w:wdr4|WDR4]]|0.493| |[[:human genes:i:iba57|IBA57]]|0.492| |[[:human genes:n:nars2|NARS2]]|0.462| |[[:human genes:p:pet112|PET112]]|0.451| |[[:human genes:p:pgm3|PGM3]]|0.446| |[[:human genes:m:mipep|MIPEP]]|0.429| |[[:human genes:t:trmt6|TRMT6]]|0.427| |[[:human genes:a:aars2|AARS2]]|0.425| |[[:human genes:p:ppa1|PPA1]]|0.422| |[[:human genes:g:gnpnat1|GNPNAT1]]|0.422| |[[:human genes:l:lars2|LARS2]]|0.416| |[[:human genes:a:adat3|ADAT3]]|0.411| |[[:human genes:y:yars2|YARS2]]|0.409| |[[:human genes:a:adat2|ADAT2]]|0.407| |[[:human genes:p:pars2|PARS2]]|0.405| |[[:human genes:d:dap3|DAP3]]|0.404| |[[:human genes:m:mrpl23|MRPL23]]|0.404| |[[:human genes:n:nsun4|NSUN4]]|0.403| |[[:human genes:m:mrps5|MRPS5]]|0.4| |[[:human genes:t:tars2|TARS2]]|0.4| Global Fraction of Cell Lines Where Essential: 143/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|1/1| |bile duct|5/28| |blood|7/28| |bone|5/26| |breast|2/33| |central nervous system|13/56| |cervix|1/4| |colorectal|1/17| |esophagus|5/13| |fibroblast|0/1| |gastric|2/16| |kidney|5/21| |liver|5/20| |lung|7/75| |lymphocyte|1/16| |ovary|4/26| |pancreas|2/24| |peripheral nervous system|2/16| |plasma cell|1/15| |prostate|0/1| |skin|4/24| |soft tissue|3/9| |thyroid|1/2| |upper aerodigestive|12/22| |urinary tract|9/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 472 * **Expression level (log2 read counts)**: 4.17 {{:chemogenomics:nalm6 dist.png?nolink |}}